-
1
-
-
77951832314
-
Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women
-
Mora S, Otvos JD, Rosenson RS, Pradhan A, Buring JE, Ridker PM. Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women. Diabetes 2010;59:1153-1160
-
(2010)
Diabetes
, vol.59
, pp. 1153-1160
-
-
Mora, S.1
Otvos, J.D.2
Rosenson, R.S.3
Pradhan, A.4
Buring, J.E.5
Ridker, P.M.6
-
2
-
-
77956864131
-
VLDL hydrolysis by LPL activates PPAR-alpha through generation of unbound fatty acids
-
Ruby MA, Goldenson B, Orasanu G, Johnston TP, Plutzky J, Krauss RM. VLDL hydrolysis by LPL activates PPAR-alpha through generation of unbound fatty acids. J Lipid Res 2010;51:2275-2281
-
(2010)
J Lipid Res
, vol.51
, pp. 2275-2281
-
-
Ruby, M.A.1
Goldenson, B.2
Orasanu, G.3
Johnston, T.P.4
Plutzky, J.5
Krauss, R.M.6
-
3
-
-
48949097245
-
Direct determination of lipoprotein particle sizes and concentrations by ion mobility analysis
-
Caulfield MP, Li S, Lee G, et al. Direct determination of lipoprotein particle sizes and concentrations by ion mobility analysis. Clin Chem 2008;54:1307-1316
-
(2008)
Clin Chem
, vol.54
, pp. 1307-1316
-
-
Caulfield, M.P.1
Li, S.2
Lee, G.3
-
4
-
-
39649101196
-
Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men
-
Risérus U, Sprecher D, Johnson T, et al. Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men. Diabetes 2008;57:332-339
-
(2008)
Diabetes
, vol.57
, pp. 332-339
-
-
Risérus, U.1
Sprecher, D.2
Johnson, T.3
-
5
-
-
77957375969
-
Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease
-
Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010;363:1341-1350
-
(2010)
N Engl J Med
, vol.363
, pp. 1341-1350
-
-
Targher, G.1
Day, C.P.2
Bonora, E.3
-
6
-
-
66449093225
-
Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans
-
Stanhope KL, Schwarz JM, Keim NL, et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009;119:1322-1334
-
(2009)
J Clin Invest
, vol.119
, pp. 1322-1334
-
-
Stanhope, K.L.1
Schwarz, J.M.2
Keim, N.L.3
-
7
-
-
23244459229
-
1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia
-
DOI 10.1161/01.ATV.0000172689.53992.25
-
Adiels M, Borén J, Caslake MJ, et al. Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia. Arterioscler Thromb Vasc Biol 2005;25:1697-1703 (Pubitemid 41098943)
-
(2005)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.25
, Issue.8
, pp. 1697-1703
-
-
Adiels, M.1
Boren, J.2
Caslake, M.J.3
Stewart, P.4
Soro, A.5
Westerbacka, J.6
Wennberg, B.7
Olofsson, S.-O.8
Packard, C.9
Taskinen, M.-R.10
-
8
-
-
33644827082
-
Overproduction of large VLDL particles is driven by increased liver fat content in man
-
DOI 10.1007/s00125-005-0125-z
-
Adiels M, Taskinen MR, Packard C, et al. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 2006;49:755-765 (Pubitemid 43357551)
-
(2006)
Diabetologia
, vol.49
, Issue.4
, pp. 755-765
-
-
Adiels, M.1
Taskinen, M.-R.2
Packard, C.3
Caslake, M.J.4
Soro-Paavonen, A.5
Westerbacka, J.6
Vehkavaara, S.7
Hakkinen, A.8
Olofsson, S.-O.9
Yki-Jarvinen, H.10
Boren, J.11
-
9
-
-
34848891301
-
1 secretion rate by insulin is associated with hepatic fat content and insulin resistance
-
DOI 10.1007/s00125-007-0790-1
-
Adiels M, Westerbacka J, Soro-Paavonen A, et al. Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance. Diabetologia 2007;50:2356-2365 (Pubitemid 47512396)
-
(2007)
Diabetologia
, vol.50
, Issue.11
, pp. 2356-2365
-
-
Adiels, M.1
Westerbacka, J.2
Soro-Paavonen, A.3
Hakkinen, A.M.4
Vehkavaara, S.5
Caslake, M.J.6
Packard, C.7
Olofsson, S.O.8
Yki-Jarvinen, H.9
Taskinen, M.R.10
Boren, J.11
-
10
-
-
0034680309
-
VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial
-
Sacks FM, Alaupovic P, Moye LA, et al. VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial. Circulation 2000;102:1886-1892
-
(2000)
Circulation
, vol.102
, pp. 1886-1892
-
-
Sacks, F.M.1
Alaupovic, P.2
Moye, L.A.3
-
11
-
-
77950202777
-
Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease
-
Petersen KF, Dufour S, Hariri A, et al. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. N Engl J Med 2010;362:1082-1089
-
(2010)
N Engl J Med
, vol.362
, pp. 1082-1089
-
-
Petersen, K.F.1
Dufour, S.2
Hariri, A.3
-
12
-
-
51649087722
-
Triglyceride-rich lipoprotein-associated apolipoprotein C-III production is stimulated by plasma free fatty acids in humans
-
Pavlic M, Valéro R, Duez H, et al. Triglyceride-rich lipoprotein-associated apolipoprotein C-III production is stimulated by plasma free fatty acids in humans. Arterioscler Thromb Vasc Biol 2008;28: 1660-1665
-
(2008)
Arterioscler Thromb Vasc Biol
, vol.28
, pp. 1660-1665
-
-
Pavlic, M.1
Valéro, R.2
Duez, H.3
-
13
-
-
39049083945
-
Plasma apolipoprotein C-III transport in centrally obese men: Associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism
-
DOI 10.1210/jc.2006-2676
-
Chan DC, Nguyen MN, Watts GF, Barrett PH. Plasma apolipoprotein C-III transport in centrally obese men: associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism. J Clin Endocrinol Metab 2008;93:557-564 (Pubitemid 351240831)
-
(2008)
Journal of Clinical Endocrinology and Metabolism
, vol.93
, Issue.2
, pp. 557-564
-
-
Chan, D.C.1
Nguyen, M.N.2
Watts, G.F.3
Barrett, P.H.R.4
-
14
-
-
42949178538
-
Liver, Muscle, and Adipose Tissue Insulin Action Is Directly Related to Intrahepatic Triglyceride Content in Obese Subjects
-
DOI 10.1053/j.gastro.2008.01.075, PII S0016508508001819
-
Korenblat KM, Fabbrini E, Mohammed BS, Klein S. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology 2008;134:1369-1375 (Pubitemid 351615354)
-
(2008)
Gastroenterology
, vol.134
, Issue.5
, pp. 1369-1375
-
-
Korenblat, K.M.1
Fabbrini, E.2
Mohammed, B.S.3
Klein, S.4
-
15
-
-
77953893410
-
Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia
-
Amaro A, Fabbrini E, Kars M, et al. Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia. Gastroenterology 2010;139:149-153
-
(2010)
Gastroenterology
, vol.139
, pp. 149-153
-
-
Amaro, A.1
Fabbrini, E.2
Kars, M.3
-
16
-
-
38649111018
-
Alterations in Adipose Tissue and Hepatic Lipid Kinetics in Obese Men and Women With Nonalcoholic Fatty Liver Disease
-
DOI 10.1053/j.gastro.2007.11.038, PII S0016508507021154
-
Fabbrini E, Mohammed BS, Magkos F, Korenblat KM, Patterson BW, Klein S. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology 2008;134:424-431 (Pubitemid 351173050)
-
(2008)
Gastroenterology
, vol.134
, Issue.2
, pp. 424-431
-
-
Fabbrini, E.1
Mohammed, B.S.2
Magkos, F.3
Korenblat, K.M.4
Patterson, B.W.5
Klein, S.6
-
17
-
-
0032900336
-
Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipid-rich VLDL
-
Horton JD, Shimano H, Hamilton RL, Brown MS, Goldstein JL. Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipid-rich VLDL. J Clin Invest 1999;103: 1067-1076 (Pubitemid 29169615)
-
(1999)
Journal of Clinical Investigation
, vol.103
, Issue.7
, pp. 1067-1076
-
-
Horton, J.D.1
Shimano, H.2
Hamilton, R.L.3
Brown, M.S.4
Goldstein, J.L.5
-
18
-
-
65249179010
-
Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction
-
Kirk E, Reeds DN, Finck BN, Mayurranjan SM, Patterson BW, Klein S. Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology 2009;136:1552-1560
-
(2009)
Gastroenterology
, vol.136
, pp. 1552-1560
-
-
Kirk, E.1
Reeds, D.N.2
Finck, B.N.3
Mayurranjan, S.M.4
Patterson, B.W.5
Klein, S.6
-
19
-
-
3242746341
-
Effects of equal weight loss with orlistat and placebo on body fat and serum fatty acid composition and insulin resistance in obese women
-
Tiikkainen M, Bergholm R, Rissanen A, et al. Effects of equal weight loss with orlistat and placebo on body fat and serum fatty acid composition and insulin resistance in obese women. Am J Clin Nutr 2004;79: 22-30 (Pubitemid 41132058)
-
(2004)
American Journal of Clinical Nutrition
, vol.79
, Issue.1
, pp. 22-30
-
-
Tiikkainen, M.1
Bergholm, R.2
Rissanen, A.3
Aro, A.4
Salminen, I.5
Tamminen, M.6
Teramo, K.7
Yki-Jarvinen, H.8
-
20
-
-
0034682621
-
Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men: A randomized, controlled trial
-
Ross R, Dagnone D, Jones PJ, et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med 2000;133:92-103 (Pubitemid 30490409)
-
(2000)
Annals of Internal Medicine
, vol.133
, Issue.2
, pp. 92-103
-
-
Ross, R.1
Dagnone, D.2
Jones, P.J.H.3
Smith, H.4
Paddags, A.5
Hudson, R.6
Janssen, I.7
-
21
-
-
70349326750
-
Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity
-
Fabbrini E, Magkos F, Mohammed BS, et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci USA 2009; 106:15430-15435
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 15430-15435
-
-
Fabbrini, E.1
Magkos, F.2
Mohammed, B.S.3
-
22
-
-
77955485237
-
Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults
-
Fabbrini E, Tamboli RA, Magkos F, et al. Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults. Gastroenterology 2010;139:448-455
-
(2010)
Gastroenterology
, vol.139
, pp. 448-455
-
-
Fabbrini, E.1
Tamboli, R.A.2
Magkos, F.3
-
23
-
-
62749178966
-
Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss
-
Gregor MF, Yang L, Fabbrini E, et al. Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss. Diabetes 2009;58:693-700
-
(2009)
Diabetes
, vol.58
, pp. 693-700
-
-
Gregor, M.F.1
Yang, L.2
Fabbrini, E.3
-
24
-
-
33751011924
-
Controversies in the management of pediatric liver disease: Hepatitis B, C and NAFLD: Summary of a single topic conference
-
DOI 10.1002/hep.21373
-
Shneider BL, González-Peralta R, Roberts EA. Controversies in the management of pediatric liver disease: hepatitis B, C and NAFLD: summary of a single topic conference. Hepatology 2006;44:1344-1354 (Pubitemid 44748385)
-
(2006)
Hepatology
, vol.44
, Issue.5
, pp. 1344-1354
-
-
Shneider, B.L.1
Gonzalez-Peralta, R.2
Roberts, E.A.3
-
26
-
-
33750002388
-
Prevalence of fatty liver in children and adolescents
-
DOI 10.1542/peds.2006-1212
-
Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics 2006;118:1388-1393 (Pubitemid 46393782)
-
(2006)
Pediatrics
, vol.118
, Issue.4
, pp. 1388-1393
-
-
Schwimmer, J.B.1
Deutsch, R.2
Kahen, T.3
Lavine, J.E.4
Stanley, C.5
Behling, C.6
-
27
-
-
68949136755
-
Glucose dysregulation and hepatic steatosis in obese adolescents: Is there a link?
-
Cali AM, De Oliveira AM, Kim H, et al. Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link? Hepatology 2009;49:1896-1903
-
(2009)
Hepatology
, vol.49
, pp. 1896-1903
-
-
Cali, A.M.1
De Oliveira, A.M.2
Kim, H.3
-
28
-
-
57949116523
-
Alterations in fatty acid kinetics in obese adolescents with increased intrahepatic triglyceride content
-
DOI 10.1038/oby.2008.494, PII OBY2008494
-
Fabbrini E, deHaseth D, Deivanayagam S, Mohammed BS, Vitola BE, Klein S. Alterations in fatty acid kinetics in obese adolescents with increased intrahepatic triglyceride content. Obesity (Silver Spring) 2009; 17:25-29 (Pubitemid 50310536)
-
(2009)
Obesity
, vol.17
, Issue.1
, pp. 25-29
-
-
Fabbrini, E.1
Dehaseth, D.2
Deivanayagam, S.3
Mohammed, B.S.4
Vitola, B.E.5
Klein, S.6
-
29
-
-
77958180000
-
Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents
-
D'Adamo E, Cali AM, Weiss R, et al. Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents. Diabetes Care 2010;33:1817-1822
-
(2010)
Diabetes Care
, vol.33
, pp. 1817-1822
-
-
D'Adamo, E.1
Cali, A.M.2
Weiss, R.3
-
30
-
-
77957970113
-
A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents
-
Santoro N, Kursawe R, D'Adamo E, et al. A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents. Hepatology 2010; 52:1281-1290
-
(2010)
Hepatology
, vol.52
, pp. 1281-1290
-
-
Santoro, N.1
Kursawe, R.2
D'Adamo, E.3
-
31
-
-
78650064129
-
Effects of PNPLA3 on liver fat and metabolic profile in Hispanic children and adolescents
-
Goran MI, Walker R, Le KA, et al. Effects of PNPLA3 on liver fat and metabolic profile in Hispanic children and adolescents. Diabetes 2010;59:3127-3130
-
(2010)
Diabetes
, vol.59
, pp. 3127-3130
-
-
Goran, M.I.1
Walker, R.2
Le, K.A.3
-
32
-
-
77950607738
-
Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease
-
Valenti L, Al-Serri A, Daly AK, et al. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 2010;51:1209-1217
-
(2010)
Hepatology
, vol.51
, pp. 1209-1217
-
-
Valenti, L.1
Al-Serri, A.2
Daly, A.K.3
-
33
-
-
62749114767
-
Interaction effect of genetic polymorphisms in glucokinase (GCK) and glucokinase regulatory protein (GCKR) on metabolic traits in healthy Chinese adults and adolescents
-
Tam CH, Ma RC, So WY, et al. Interaction effect of genetic polymorphisms in glucokinase (GCK) and glucokinase regulatory protein (GCKR) on metabolic traits in healthy Chinese adults and adolescents. Diabetes 2009;58:765-769
-
(2009)
Diabetes
, vol.58
, pp. 765-769
-
-
Tam, C.H.1
Ma, R.C.2
So, W.Y.3
-
34
-
-
50949132578
-
The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population
-
DESIR Study Group
-
Vaxillaire M, Cavalcanti-Proença C, Dechaume A, et al.; DESIR Study Group. The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population. Diabetes 2008; 57:2253-2257
-
(2008)
Diabetes
, vol.57
, pp. 2253-2257
-
-
Vaxillaire, M.1
Cavalcanti-Proença, C.2
Dechaume, A.3
-
35
-
-
70349980881
-
The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver
-
Beer NL, Tribble ND, McCulloch LJ, et al. The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver. Hum Mol Genet 2009;18:4081-4088
-
(2009)
Hum Mol Genet
, vol.18
, pp. 4081-4088
-
-
Beer, N.L.1
Tribble, N.D.2
McCulloch, L.J.3
-
36
-
-
77951874018
-
NASH CRN. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis
-
Sanyal AJ, Chalasani N, Kowdley KV, et al.; NASH CRN. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 2010;362:1675-1685
-
(2010)
N Engl J Med
, vol.362
, pp. 1675-1685
-
-
Sanyal, A.J.1
Chalasani, N.2
Kowdley, K.V.3
-
37
-
-
77953356804
-
Gluttony, sloth and the metabolic syndrome: A roadmap to lipotoxicity
-
Unger RH, Scherer PE. Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity. Trends Endocrinol Metab 2010;21:345-352
-
(2010)
Trends Endocrinol Metab
, vol.21
, pp. 345-352
-
-
Unger, R.H.1
Scherer, P.E.2
-
38
-
-
0035834630
-
Hyperglycemia-induced production of acute phase reactants in adipose tissue
-
Lin Y, Rajala MW, Berger JP, Moller DE, Barzilai N, Scherer PE. Hyperglycemia-induced production of acute phase reactants in adipose tissue. J Biol Chem 2001; 276:42077-42083
-
(2001)
J Biol Chem
, vol.276
, pp. 42077-42083
-
-
Lin, Y.1
Rajala, M.W.2
Berger, J.P.3
Moller, D.E.4
Barzilai, N.5
Scherer, P.E.6
-
39
-
-
77957838795
-
Weight loss and lipolysis promote a dynamic immune response inmurine adipose tissue
-
Kosteli A, Sugaru E, Haemmerle G, et al. Weight loss and lipolysis promote a dynamic immune response inmurine adipose tissue. J Clin Invest 2010;120:3466-3479
-
(2010)
J Clin Invest
, vol.120
, pp. 3466-3479
-
-
Kosteli, A.1
Sugaru, E.2
Haemmerle, G.3
-
40
-
-
77749242629
-
Enhanced metabolic flexibility associated with elevated adiponectin levels
-
Asterholm IW, Scherer PE. Enhanced metabolic flexibility associated with elevated adiponectin levels. Am J Pathol 2010;176:1364-1376
-
(2010)
Am J Pathol
, vol.176
, pp. 1364-1376
-
-
Asterholm, I.W.1
Scherer, P.E.2
-
41
-
-
84860493578
-
Lipid mediators of insulin resistance
-
Holland WL, Knotts TA, Chavez JA, Wang LP, Hoehn KL, Summers SA. Lipid mediators of insulin resistance. Nutr Rev 2007;65:S39-S46
-
(2007)
Nutr Rev
, vol.65
-
-
Holland, W.L.1
Knotts, T.A.2
Chavez, J.A.3
Wang, L.P.4
Hoehn, K.L.5
Summers, S.A.6
-
42
-
-
63249117466
-
Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance
-
Haus JM, Kashyap SR, Kasumov T, et al. Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes 2009;58:337-343
-
(2009)
Diabetes
, vol.58
, pp. 337-343
-
-
Haus, J.M.1
Kashyap, S.R.2
Kasumov, T.3
-
43
-
-
77449161528
-
Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content
-
Coen PM, Dubé JJ, Amati F, et al. Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content. Diabetes 2010;59:80-88
-
(2010)
Diabetes
, vol.59
, pp. 80-88
-
-
Coen, P.M.1
Dubé, J.J.2
Amati, F.3
-
44
-
-
77956395533
-
The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes
-
Cusi K. The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes. Curr Diab Rep 2010;10:306-315
-
(2010)
Curr Diab Rep
, vol.10
, pp. 306-315
-
-
Cusi, K.1
-
45
-
-
68349137821
-
Normalization of obesity-associated insulin resistance through immunotherapy
-
Winer S, Chan Y, Paltser G, et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 2009; 15:921-929
-
(2009)
Nat Med
, vol.15
, pp. 921-929
-
-
Winer, S.1
Chan, Y.2
Paltser, G.3
-
46
-
-
34447511196
-
Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women
-
DOI 10.1001/jama.298.3.299
-
Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007;298:299-308 (Pubitemid 47080484)
-
(2007)
Journal of the American Medical Association
, vol.298
, Issue.3
, pp. 299-308
-
-
Nordestgaard, B.G.1
Benn, M.2
Schnohr, P.3
Tybjaerg-Hansen, A.4
-
47
-
-
0041666333
-
Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?
-
DECODE Study Group, European Diabetes Epidemiology Group
-
DECODE Study Group, European Diabetes Epidemiology Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care 2003;26:688-696
-
(2003)
Diabetes Care
, vol.26
, pp. 688-696
-
-
-
48
-
-
33846623798
-
Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets
-
DOI 10.1161/CIRCULATIONAHA.104.475673, PII 0000301720070130000015
-
Brown JD, Plutzky J. Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets. Circulation 2007;115:518-533 (Pubitemid 46184203)
-
(2007)
Circulation
, vol.115
, Issue.4
, pp. 518-533
-
-
Brown, J.D.1
Plutzky, J.2
-
49
-
-
0028865357
-
High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules
-
Cockerill GW, Rye KA, Gamble JR, Vadas MA, Barter PJ. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol 1995;15:1987-1994
-
(1995)
Arterioscler Thromb Vasc Biol
, vol.15
, pp. 1987-1994
-
-
Cockerill, G.W.1
Rye, K.A.2
Gamble, J.R.3
Vadas, M.A.4
Barter, P.J.5
-
50
-
-
33645298823
-
High-density lipoprotein hydrolysis by endothelial lipase activates PPARalpha: A candidate mechanism for high-density lipoprotein-mediated repression of leukocyte adhesion
-
Ahmed W, Orasanu G, Nehra V, et al. High-density lipoprotein hydrolysis by endothelial lipase activates PPARalpha: a candidate mechanism for high-density lipoprotein-mediated repression of leukocyte adhesion. Circ Res 2006;98:490-498
-
(2006)
Circ Res
, vol.98
, pp. 490-498
-
-
Ahmed, W.1
Orasanu, G.2
Nehra, V.3
-
51
-
-
77955281827
-
Lack of association between common genetic variation in endothelial lipase (LIPG) and the risk for CAD and DVT
-
Vergeer M, Cohn DM, Boekholdt SM, et al. Lack of association between common genetic variation in endothelial lipase (LIPG) and the risk for CAD and DVT. Atherosclerosis 2010;211:558-564
-
(2010)
Atherosclerosis
, vol.211
, pp. 558-564
-
-
Vergeer, M.1
Cohn, D.M.2
Boekholdt, S.M.3
-
52
-
-
34249977327
-
Retinaldehyde represses adipogenesis and diet-induced obesity
-
DOI 10.1038/nm1587, PII NM1587
-
Ziouzenkova O, Orasanu G, Sharlach M, et al. Retinaldehyde represses adipogenesis and diet-induced obesity. Nat Med 2007;13:695-702 (Pubitemid 46889756)
-
(2007)
Nature Medicine
, vol.13
, Issue.6
, pp. 695-702
-
-
Ziouzenkova, O.1
Orasanu, G.2
Sharlach, M.3
Akiyama, T.E.4
Berger, J.P.5
Viereck, J.6
Hamilton, J.A.7
Tang, G.8
Dolnikowski, G.G.9
Vogel, S.10
Duester, G.11
Plutzky, J.12
|